by QIMR Berghofer Graphical overview of epigenetic reprograming in hamster bronchiolar epithelium and human CD14+ monocytes. Credit: Nature Communications (2023). DOI: 10.1038/s41467-023-39341-4 A new drug developed by QIMR Berghofer could transform the treatment of COVID-19 by potentially protecting against infection by any SARS-CoV-2 variant and reversing the persistent inflammation that is a major driver of debilitating long COVID....
by Brigham and Women’s Hospital Credit: Unsplash/CC0 Public Domain Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome are debilitating conditions with similar symptoms. Neither condition has diagnostic tests or treatments approved by the Food and Drug Administration (FDA) and each cost the United States billions of dollars each year in direct medical expenses and lost productivity. Doctors and researchers...
by Rush University Medical Center INSPIRE is CDC- funded collaboration of eight major academic medical centers seeking to better understand the long-term effects of COVID. Credit: RUSH Production Group The latest data from the nationwide INSPIRE study assessing the long-term symptoms and outcomes of the COVID-19 virus in nearly 6000 participants identifies four clinically distinct symptom...
Lauran Neergaard May 26, 2023, 04:18 AM EDT WASHINGTON (AP) — About 10% of people appear to suffer long COVID after an omicron infection, a lower estimate than earlier in the pandemic, according to a study of nearly 10,000 Americans that aims to help unravel the mysterious condition. Early findings from the National Institutes of Health’s...
HEALTH 21 May 2023 By FELICITY NELSON (Oleg Breslavtsev/Getty Images) Long COVID has more than 200 potential symptoms and can affect almost every organ in the body. With more than 65 million people now estimated to live with this often-disabling condition worldwide, and numbers growing daily, there is a desperate need to understand the underlying biology driving it. There are...
By WEILL CORNELL MEDICINE MAY 13, 2023 A recent study using electronic health records from the National Institutes of Health’s RECOVER Initiative, analyzed the persistence of symptoms after SARS-CoV-2 infection (long COVID) among diverse populations in the United States. The findings emphasized the need for further investigation to improve the diagnosis and treatment of the disease. The...
by Kyle B. Enfield, The Conversation Credit: Pixabay/CC0 Public Domain A patient of mine, once a marathon runner, now gets tired just walking around the block. She developed COVID-19 during the 2020 Christmas holiday and saw me during the summer of 2021. Previously, her primary care doctor had recommended a graded exercise program. But exercise exhausted...
by European Society of Cardiology Credit: Pixabay/CC0 Public Domain A small randomized trial in patients with post-COVID syndrome has found that hyperbaric oxygen therapy promotes restoration of the heart’s ability to contract properly. The research is presented at EACVI 2023, a scientific congress of the European Society of Cardiology (ESC). “The study suggests that hyperbaric oxygen therapy can be beneficial...
Reviewed by Emily Henderson, B.Sc. May 9 2023 COVID-19, the disease resulting from SARS-CoV-2 infection, is associated with highly variable clinical outcomes that range from asymptomatic disease to death. For those with milder infections, COVID-19 can produce respiratory infection symptoms (cough, congestion, fever) and sensory phenotypes such as headache and loss of sense of smell....
Three years in, scientists still aren’t quite sure why some people get stuck with the syndrome and its cluster of debilitating symptoms long after their COVID-19 infection has cleared, while others breeze through and quickly return to a normal life. In part, that’s because long COVID is so hard to pin down. For some patients,...
